Scott Christensen

Title(s)Professor, Hematology and Oncology
SchoolSchool of Medicine
AddressCancer Ctr So, #3016
CA 95817
Phone916-734-3772
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A High-Resolution National-Scale Hydrologic Forecast System from a Global Ensemble Land Surface Model. J Am Water Resour Assoc. 2016 Aug; 52(4):950-964. Snow AD, Christensen SD, Swain NR, Nelson EJ, Ames DP, Jones NL, Ding D, Noman NS, David CH, Pappenberger F, Zsoter E. PMID: 31423076; PMCID: PMC6686479.
      View in: PubMed   Mentions: 1  
    2. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series. J Am Acad Dermatol. 2015 Oct; 73(4):645-54. Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Maverakis E. PMID: 26259990.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    3. A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas. Br J Cancer. 2015 May 12; 112(10):1644-51. Eroglu Z, Tawbi HA, Hu J, Guan M, Frankel PH, Ruel NH, Wilczynski S, Christensen S, Gandara DR, Chow WA. PMID: 25897676; PMCID: PMC4430716.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    4. Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity. Ann Surg Oncol. 2014 May; 21(5):1616-23. Canter RJ, Borys D, Olusanya A, Li CS, Lee LY, Boutin RD, Christensen SD, Tamurian RM, Monjazeb AM. PMID: 24554062; PMCID: PMC4153793.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    5. Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528. Cancer Chemother Pharmacol. 2013 Nov; 72(5):1089-96. Gadgeel SM, Lew DL, Synold TW, LoRusso P, Chung V, Christensen SD, Smith DC, Kingsbury L, Hoering A, Kurzrock R. PMID: 24057042; PMCID: PMC4072025.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    6. Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors. Anticancer Drugs. 2013 Jul; 24(6):636-40. Semrad TJ, Eddings C, Dutia MP, Christensen S, Lara PN. PMID: 23698253; PMCID: PMC4153755.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    7. Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities. JAMA Surg. 2013 Jul; 148(7):632-9. Wasif N, Smith CA, Tamurian RM, Christensen SD, Monjazeb AM, Martinez SR, Canter RJ. PMID: 23552630.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    8. The acute effects of various types of stretching static, dynamic, ballistic, and no stretch of the iliopsoas on 40-yard sprint times in recreational runners. Int J Sports Phys Ther. 2012 Oct; 7(5):540-7. Wallmann HW, Christensen SD, Perry C, Hoover DL. PMID: 23091787; PMCID: PMC3474300.
      View in: PubMed   Mentions: 5  
    9. Aflibercept (VEGF Trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin. Clin Cancer Res. 2011 Oct 15; 17(20):6574-81. Tarhini AA, Frankel P, Margolin KA, Christensen S, Ruel C, Shipe-Spotloe J, Gandara DR, Chen A, Kirkwood JM. PMID: 21880788; PMCID: PMC3196047.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    10. Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors. Ann Oncol. 2012 Apr; 23(4):1023-9. Chew HK, Somlo G, Mack PC, Gitlitz B, Gandour-Edwards R, Christensen S, Linden H, Solis LJ, Yang X, Davies AM. PMID: 21778300.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    11. Influence of specialty and clinical experience on treatment sequencing in the multimodal management of soft tissue extremity sarcoma. Ann Surg Oncol. 2012 Feb; 19(2):504-10. Wasif N, Tamurian RM, Christensen S, Do L, Martinez SR, Chen SL, Canter RJ. PMID: 21769468.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. A model for rural oncology. J Oncol Pract. 2011 May; 7(3):168-71. Heifetz LJ, Christensen SD, Devere-White RW, Meyers FJ. PMID: 21886498; PMCID: PMC3092657.
      View in: PubMed   Mentions: 5     Fields:    
    13. A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial. Invest New Drugs. 2012 Apr; 30(2):741-8. Li T, Christensen SD, Frankel PH, Margolin KA, Agarwala SS, Luu T, Mack PC, Lara PN, Gandara DR. PMID: 20967484; PMCID: PMC3277821.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    14. Metastatic breast cancer mimicking benign fatty liver infiltration. Breast J. 2008 Jan-Feb; 14(1):108. Martinez SR, Hagge RJ, Christensen SD, Webb JM. PMID: 18186875.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Phase I study of two different schedules of bortezomib and pemetrexed in advanced solid tumors with emphasis on non-small cell lung cancer. J Thorac Oncol. 2007 Dec; 2(12):1112-6. Davies AM, Ho C, Metzger AS, Beckett LA, Christensen S, Tanaka M, Lara PN, Lau DH, Gandara DR. PMID: 18090584.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    16. CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium. Cancer. 2005 Sep 01; 104(5):1045-8. Margolin K, Longmate J, Baratta T, Synold T, Christensen S, Weber J, Gajewski T, Quirt I, Doroshow JH. PMID: 16007689.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    17. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage. 2004 Dec; 28(6):548-56. Meyers FJ, Linder J, Beckett L, Christensen S, Blais J, Gandara DR. PMID: 15589080.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    18. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004 Sep-Oct; 10(5):294-300. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN. PMID: 15530258.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    19. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001 Mar 15; 19(6):1728-33. Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. PMID: 11251003.
      View in: PubMed   Mentions: 246     Fields:    Translation:Humans
    20. Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma. Cancer Biother Radiopharm. 1999 Jun; 14(3):167-76. O'Donnell RT, Leigh BR, Christensen SD, Goldstein DS, Kukis DL, Shen S, Yuan A, DeNardo DA, Kroger LA, DeNardo GL. PMID: 10850301.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    Scott's Networks
    Concepts (125)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California